2023] THE RIGHT TO PERSONALITY 297
enhancement.
27
As would be expected, both medical treatments and
cognitive enhancements raise legal and ethical issues that have caused
spirited legal and medical debates over their appropriate uses.
28
The mandatory interventions in the six scenarios, however, pose
difficult questions in part because they fall somewhere on the spectrum
between medical treatment and cognitive enhancement. Two of our
defendants do not have a “disease” for the therapy to treat. The third,
Defendant One, has alcoholism, which is not universally considered a
disease
29
and at a minimum is treated in a categorically different manner
than traditionally conceived diseases such as leukemia.
30
Nor do our
interventions properly qualify as enhancements since our defendants do not
have “normal” functioning as to the targeted trait or characteristic. None of
the interventions in our scenarios are aimed at making the defendant better
than average through improvements, only closer to average. Indeed, the
interventions are targeted at defusing a trait or characteristic that prevents
the defendant from being able to follow societal and legal rules.
One of the first cases in the United States to result in a sentence
including chemical castration involved just such a defendant. In that case,
the Michigan Court of Appeals described the defendant as “like a furnace
which overheats a house if the thermostat is set too high”
31
and saw the use
of chemical castration as a way to “reset” the thermostat.
32
Rather than shoehorn the interventions into the category of medical
treatment or cognitive enhancement, this Article proposes recognizing a
27
One survey showed that almost seven percent of U.S. college students have taken stimulants in
the hopes of achieving higher grades. Henry Greely et al., Towards Responsible Use of
Cognitive-Enhancing Drugs by the Healthy, 456 N
ATURE
702, 702 (2008).
28
See, e.g., Cauley, supra note 8, at 494–95 (“Chemical castration . . . could serve all four of the
sentencing goals of our modern penal system. Similar to drug-addicted criminals who undergo
therapeutic drug treatment while incarcerated, it seems evenhanded to offer sex criminals any available
corrective or rehabilitative drug treatments.”). But see Greely, supra note 9, at 1105 (“[W]e need to be
vigilant to avoid the over-enthusiastic adoption of unproven new ‘treatments’—practiced in the brains
of, at best, unsympathetic and, at worst, despised people.”). See generally Emily R. Murphy, Paved with
Good Intentions: Sentencing Alternatives from Neuroscience and the Policy of Problem-Solving Courts,
37 L
AW
&
P
SYCH
.
R
EV
.
83, 85 (2013) (highlighting “new neuroscience treatments” that could be used in
criminal justice settings, and the “risks of their misuse and potential harms to constitutional rights,
individual autonomy, and ultimately institutional competency and legitimacy”).
29
See, e.g., Matt Dean, Comment, Manning, Powell, and the Habitual Misunderstanding of
Addiction, 94 S
T
.
J
OHN
’
S
L.
R
EV
.
587,
610
(2020) (noting that although “[a]ddiction is now commonly
spoken of as a disease rather than a moral failing,” there is still a moral stigma surrounding it, so much
so that “[e]ven recovering alcoholics, for whom the disease model is the very foundation of their
treatment efforts, often speak of addiction in terms of ‘moral inventory,’ . . . and ‘character defects’”).
30
See James R. McKay & Susanne Hiller-Sturmhöfel, Treating Alcoholism ass a Chronic Disease:
Approaches to Long-Term Continuing Care, 33 A
LCOHOL
R
SCH
.
&
H
EALTH
356, 356 (2011) (describing
alcoholism interventions such as “group counseling [or] cognitive behavioral therapy” designed to
“reduce the need for additional treatment episodes”).
31
People v. Gauntlett, 352 N.W.2d 310, 313 (Mich. Ct. App. 1984) (vacating a sentence of chemical
castration for lack of authority because the state did not have a chemical castration statute in place).
32
Id.